- Supplementary Figure S1 Sequencing coverage of ctDNA, tDNA or white blood cell gDNA
- Supplementary Figure S2 Landscape of genetic alterations in lung cancer patients
- Supplementary Table S1 Summary of clinical pathological information
- Supplementary Table S2 50-gene panel and probe information
- Supplementary Table S3 Relationship between cfDNA concentration and stages of lung cancer
- Supplementary Table S4 Sequencing data of the 30 patients
- Supplementary Table S5 ctDNA detection and the diagnosis of SOL of the lung cancer patients
- Supplementary Table S6 Detection of plasma protein biomarkers